Gastrointestinal Cancer Research
Todd S. Crocenzi, M.D.
, is exploring ways in which immunotherapy can be integrated effectively into standard treatments for colorectal cancer and other cancers of the gastrointestinal system.
Dr. Crocenzi serves as medical director of
Providence Gastrointestinal Cancer Program
as well as leading the clinical Gastrointestinal Cancer Research program at the Robert W. Franz Cancer Research Center. Dr. Crocenzi earned his medical degree from Jefferson Medical College and served as a research fellow and instructor at Dartmouth Medical School. “One of my personal research interests, and of my colleagues here, is immunotherapy. This is an area of research that is really beginning to blossom, but requires further exploration,” says Dr. Crocenzi.
Providence Gastrointestinal Cancer Research is establishing four multidisclipinary collaborative working groups: colorectal, gastroesophageal, hepatobiliary and pancreatic. The purpose of this effort is to design and implement research projects that use the array of disciplines represented, while building upon existing Providence programs, such as Providence Cancer Support Services and Providence Integrative Medicine.